NCT Number: NCT07318493
The purpose of this study is to determine if the use of antiseptic-coated sutures is better than the use of the standard sutures in preventing postoperative fistulas within 90 days after pancreatoduodenectomy.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Cleveland Clinic Akron, Akron, Ohio, United States
This study is a randomized-controlled trial comparing the rate of post-operative pancreatic fistula (POPF) in patients undergoing pancreatoduodenectomy. This is a superiority study designed to determine whether the use of antiseptic-coated sutures (intervention arm) is superior to standard sutures (control arm) in regard to clinically significant POPF within 90 days following pancreatoduodenectomy. Patients will be randomized to receive either a pancreatoduodenectomy surgery utilizing antiseptic coated sutures or with non-coated standard sutures. The study hypothesize that the use of antiseptic-coated sutures will be associated with a reduction in the rate of POPF. Both sutures are currently available at our center and utilized in the procedure of interest.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This is an operation to treat tumors and other conditions in the pancreas, small intestine, and bile ducts. It involves removing the head of the pancreas, the first part of the small intestine, the gallbladder, and the bile duct. Part of the procedure involves sutures. A suture(s) is a stitch or row of stitches holding together the edges of a wound or surgical incision
Triclosan/antiseptic -coated suture will be used. Ethicon PDSTM Plus Antibacterial Suture will be used at the layer of the pancreatojejunostomy and for the duration of the case.
Time frame: up to 90 days post-operative
comparison of the rate of postoperative pancreatic fistula- Biochemical leak
Time frame: up to 90 days post-operative
Comparison of the rate of postoperative pancreatic fistula-Grade B
Time frame: up to 90-day post operative
Comparison of the rate of postoperative pancreatic fistula-Grade C
Time frame: up to 90-days post-operative
Improvement in Rate of clinically significant POPF (Grade B and C defined by ISGLS definition)
Time frame: up to 90-days post-operative
Improvement in SSI rates between groups using CDC classification (superficial, deep, organ space)
Time frame: up to 90-day post operative
Duration of hospital admission, measured in days, during index presentation for pancreatoduodenectomy. This will subsequently be compared among our two cohorts (standard suture vs antiseptic suture)
Time frame: up to 90-day post operative
Duration of Intensive care unit admission, measured in days, during index presentation for pancreatoduodenectomy, or during convalescence from surgery. This will subsequently be compared among our two cohorts (standard suture vs antiseptic suture)
Time frame: up to 90-day post operative
An infection that occurs in the part of the body where the surgery took place and includes superficial, deep, and organ space infections
Time frame: Up to 90 days post-operative
Non-healing incisional wound, fascial disruption, skin or soft tissue ischemia, skin or soft tissue necrosis, wound serous or purulent drainage, stitch abscess, seroma, hematoma, wound dehiscence, and enterocutaneous fistula
Time frame: up to 90 days post-operative
Interventions to address wound healing issues or complications including wound opening or debridement, suture excision, percutaneous drainage. This includes to address superficial, deep, and organ space healing concerns
Time frame: Up to 90 days post-operative
Postoperative interventions related to clinically relevant postoperative pancreatic leak (defined by 2016 International Study Group of Pancreatic Fistula) including percutaneous, endoscopic and surgical interventions.
Contact information is provided by the study sponsor or research team.
The Cleveland Clinic
Other
Does Antiseptic Coated Suture Reduce Pancreatic Fistula Rate After Pancreatoduodenectomy: A Randomized Controlled Trial
Acronym: Triclosan
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06953193
Cardiovascular Diseases, Digestive System Diseases
Mexico City, Mexico
View Trial DetailsNCT07423650
Agnosia, Multimodal Analgesia
Cluj-Napoca, Cluj, Romania
View Trial DetailsNCT06319755
Digestive System Diseases, Digestive System Neoplasms
Camperdown, New South Wales, Australia
View Trial DetailsNCT06283160
Acute Pancreatitis, Digestive System Diseases
Besançon, France
View Trial Details